CME
59
3
BEN
36
4
NSC
33
6
PBI
30
-8
MCO
67
3
BLK
46
2
HIG
48
5
PSA
43
6
CMS
57
2
LRCX
56
4
TRV
34
4
KO
44
2
TAP
57
6
BDX
59
3
AMG
33
-11
WBA
41
3
AN
49
2
LMT
29
-5
ZBH
69
15
IP
53
3
CME
59
3
BEN
36
4
NSC
33
6
PBI
30
-8
MCO
67
3
BLK
46
2
HIG
48
5
PSA
43
6
CMS
57
2
LRCX
56
4
TRV
34
4
KO
44
2
TAP
57
6
BDX
59
3
AMG
33
-11
WBA
41
3
AN
49
2
LMT
29
-5
ZBH
69
15
IP
53
3
Financhill
Back

Novartis AG Vs. Nukkleus Industry Stock Comparison

Buy
71

NVSEF
Novartis AG

Last Price:
$94.70
Seasonality Move:
-2.92%
Sell
46

NUKK
Nukkleus

Last Price:
$40.15
Seasonality Move:
-21.57%
Buy
71
Novartis AG (NVSEF) is a Buy

Is Novartis AG a Buy, Sell or Hold?

  • The current Novartis AG [NVSEF] share price is $94.70. The Score for NVSEF is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • NVSEF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
Nukkleus (NUKK) is a Sell

Is Nukkleus a Buy, Sell or Hold?

  • The current Nukkleus [NUKK] share price is $40.00. The Score for NUKK is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • NUKK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NVSEF Stock Price Chart

What is Novartis AG's stock price today?

  • The Novartis AG share price today is $94.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVSEF is experiencing slight buying pressure.

NUKK Stock Price Chart

What is Nukkleus's stock price today?

  • The Nukkleus share price today is $40.00
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NUKK is experiencing slight selling pressure.

NVSEF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.37 Sell
Relative Strength Index (14 RSI): 34.85 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (97.5 - 103.28) Sell
Bollinger Bands (100): (102.68 - 115.04) Sell

NUKK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.69 Buy
Relative Strength Index (14 RSI): 77.28 Buy
Chaikin Money Flow: -1366926 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (-7.5 - 22.6) Buy
Bollinger Bands (100): (-4.22 - 11.5) Buy

NVSEF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 97.48 Sell
20-day SMA: 100.02 Sell
50-day SMA: 104.68 Sell
200-day SMA: 104.53 Sell
8-day EMA: 97.3 Sell
20-day EMA: 99.59 Sell
50-day EMA: 103.34 Sell
200-day EMA: 104.12 Sell

NUKK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.07 Buy
20-day SMA: 9 Buy
50-day SMA: 4.99 Buy
200-day SMA: 4.78 Buy
8-day EMA: 26.51 Buy
20-day EMA: 14.21 Buy
50-day EMA: 7.47 Buy
200-day EMA: 11.77 Buy

Novartis AG Earnings Growth & NVSEF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.17 per share, and a decrease next year of $0.00 per share.

Nukkleus Earnings Growth & NUKK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Novartis AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nukkleus Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):